0001193125-19-214053.txt : 20190807 0001193125-19-214053.hdr.sgml : 20190807 20190807102609 ACCESSION NUMBER: 0001193125-19-214053 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190806 DATE AS OF CHANGE: 20190807 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87690 FILM NUMBER: 191004219 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CANTEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001374961 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1792 BELL TOWER LANE STREET 2: SUITE 222 CITY: WESTON STATE: FL ZIP: 33326 BUSINESS PHONE: 954-315-3660 MAIL ADDRESS: STREET 1: 1792 BELL TOWER LANE STREET 2: SUITE 222 CITY: WESTON STATE: FL ZIP: 33326 FORMER COMPANY: FORMER CONFORMED NAME: PARINGENIX INC DATE OF NAME CHANGE: 20060907 SC 13G 1 d788061dsc13g.htm SC 13G SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Chimerix, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

16934W106

(CUSIP Number)

July 26, 2019

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)

 

Rule 13d-1(c)

 

Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 16934W106    13G    Page 2 of 5 Pages

 

  1.    

  NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

   Cantex Pharmaceuticals, Inc. 41-2035780

  2.    

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☐        (b)  ☐

  3.    

  SEC USE ONLY

 

  4.    

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

   Delaware

NUMBER OF

SHARES

  BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.     

  SOLE VOTING POWER

 

   10,000,000

  6.     

  SHARED VOTING POWER

 

  7.     

  SOLE DISPOSITIVE POWER

 

   10,000,000

  8.     

  SHARED DISPOSITIVE POWER

 

  9.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

   10,000,000

10.    

  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

11.    

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

   16.37%

12.    

  TYPE OF REPORTING PERSON (see instructions)

 

   CO


CUSIP No. 16934W106    13G    Page 3 of 5 Pages

 

Item 1.

 

            (a)    Name of Issuer
Chimerix, Inc.
   (b)   

Address of Issuer’s Principal Executive Offices
2505 Meridian Parkway, Suite 100

Durham, NC 27713

Item 2.

 

            (a)    Name of Person Filing
Cantex Pharmaceuticals, Inc.
   (b)   

Address of the Principal Office or, if none, residence
1792 Bell Tower Lane

Weston, FL 33326

   (c)    Citizenship
Delaware, United States
   (d)    Title of Class of Securities
Common Stock
   (e)    CUSIP Number
16934W106

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

            (a)       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
   (b)       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
   (c)       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
   (d)       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
   (e)       An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
   (f)       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
   (g)       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
   (h)       A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
   (i)       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
   (j)       Group, in accordance with §240.13d-1(b)(1)(ii)(J).


CUSIP No. 16934W106    13G    Page 4 of 5 Pages

 

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)    Amount beneficially owned: 10,000,000
(b)    Percent of class: 16.37%
(c)    Number of shares as to which the person has:
   (i)    Sole power to vote or to direct the vote: 10,000,000.
   (ii)    Shared power to vote or to direct the vote: 0
   (iii)    Sole power to dispose or to direct the disposition of: 10,000,000
   (iv)    Shared power to dispose or to direct the disposition of: 0

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ☐.

Instruction. Dissolution of a group requires a response to this item.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

Not Applicable.

Item 9. Notice of Dissolution of Group.

Not Applicable.

Item 10. Certification.

 

  (a)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

  (b)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


CUSIP No. 16934W106    13G    Page 5 of 5 Pages

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

August 6, 2019

Date

/s/ Juan F. Rodriguez

Signature

Juan F. Rodriguez, Chief Financial Officer

Name/Title